Devita, Hellman, and Rosenberg's Cancer

LWBK1006-13 LWW-Govindan-Review November 24, 2011 11:22

Chapter 13•Cancer Screening 143

Question 13.9. More frequent screening for colorectal cancer is recommended in all of

the following situations, EXCEPT:

A. Patients with one second-degree relative with colorectal cancer

B. Gene carriers for familial adenomatous polyposis

C. Gene carrier for hereditary nonpolyposis colon cancer

D. Patients with ulcerative colitis

Question 13.10. Almost all cervical cancers are associated with infection by sexually trans-

mitted HPV. Of the following statements about HPV infection in young

women (in their teens and 20s), which one is INCORRECT?

A. HPV infection is common in young, sexually active women.

B. HPV infection is often transient in young women.

C. In young women, most cases of low-grade squamous intraepithelial

lesion (LSIL) will regress without treatment.

D. HPV infection and LSIL are the earliest stages in the development of

cervical cancer and require aggressive treatment.

Question 13.11. Regarding population screening for ovarian cancer, which of the follow-

ing tests have been proven effective? Choose one or more:

A. Annual pelvic examination

B. Annual measurement of serum CA 125

C. Two-stage screening: annual CA 125 then transvaginal ultrasound if

elevated CA 125

D. None of the above

Question 13.12. The United States Preventive Services Task Force, the American College of

Obstetricians and Gynecologists, and the American College of Physicians

agree on which one of the following recommendations for ovarian cancer

screening?

A. Annual pelvic examination for women ages 20 to 70 years

B. No population-based screening is recommended.

C. Transvaginal ultrasound every 5 years

D. Annual serum CA 125 measurement

Question 13.13. Women are at increased risk of breast cancer if they have:

A. Lobular carcinoma in situ (LCIS)

B. Atypical ductal hyperplasia (ADH)

C. A history of mantle radiation for Hodgkin’s lymphoma

D. All of the above